Table 3.

Recurrence-free survival probabilities.

Timepoint	Clinical Trial RFS (95% CI)	Synthetic Control RFS (95% CI)
12 months	81.2% (67.7-94.8%)	93.9% (87.2-100%)
24 months	65.6% (49.2-82.1%)	73.8% (60.2-87.3%)
32 months	50.0% (32.7-67.3%)	56.6% (39.8-73.4%)
36 months	50.0% (32.7-67.3)	42.5% (25.1-59.9%)